Citadel Advisors »

Coya Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Coya Therapeutics (COYA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Coya Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Coya Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Coya Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $123k 17k 7.41
2023-06-30 $43k 11k 4.07

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Coya Therapeutics

Greenlight Capital
AIGH Capital Management
Raymond James & Associates
CM Management
Vanguard Group
Worth Venture Partners
Potomac Capital Management
Citadel Advisors
Mirador Capital Partners
UBS Group
Tradition Wealth Management
Royal Bank of Canada
Tucker Asset Management
Jpmorgan Chase & Co
Wells Fargo & Company

View all funds holding Coya Therapeutics